GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jiangsu Nanfang Medical Co Ltd (SHSE:603880) » Definitions » Capex-to-Operating-Income

Jiangsu Nanfang Medical Co (SHSE:603880) Capex-to-Operating-Income : 0.00 (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Jiangsu Nanfang Medical Co Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Jiangsu Nanfang Medical Co's Capital Expenditure for the three months ended in Mar. 2025 was ¥-4.04 Mil. Its Operating Income for the three months ended in Mar. 2025 was ¥-5.53 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Jiangsu Nanfang Medical Co Capex-to-Operating-Income Historical Data

The historical data trend for Jiangsu Nanfang Medical Co's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Nanfang Medical Co Capex-to-Operating-Income Chart

Jiangsu Nanfang Medical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 47.32 - - -

Jiangsu Nanfang Medical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.90 - - -

Competitive Comparison of Jiangsu Nanfang Medical Co's Capex-to-Operating-Income

For the Medical Instruments & Supplies subindustry, Jiangsu Nanfang Medical Co's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Nanfang Medical Co's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Jiangsu Nanfang Medical Co's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Jiangsu Nanfang Medical Co's Capex-to-Operating-Income falls into.


;
;

Jiangsu Nanfang Medical Co Capex-to-Operating-Income Calculation

Jiangsu Nanfang Medical Co's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-32.405) / -141.812
=N/A

Jiangsu Nanfang Medical Co's Capex-to-Operating-Income for the quarter that ended in Mar. 2025 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-4.037) / -5.527
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangsu Nanfang Medical Co  (SHSE:603880) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Jiangsu Nanfang Medical Co Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Jiangsu Nanfang Medical Co's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Nanfang Medical Co Business Description

Traded in Other Exchanges
N/A
Address
Guo Xiang Road, Economic Development Zone, Jiangsu Province, Wujin, CHN, 213149
Jiangsu Nanfang Medical Co Ltd is a domestic adhesive dressing production enterprise that integrates research and development, production, and sales. It produces a band-aid in China. The company is focused on the development of self-owned brand products such as first-aid kits, sports protection products, and care products on the basis of the original series of Miaoshou medical dressings.
Executives
Zhou Min Director
Li Ping Director
Xiang Qin Hua Director
Li Fei Director
Wu Ya Fen senior management
Li Yong Ping Director
Zhuang Guo Ping Director
Li Yong Zhong Director
Li Yan Hua Director

Jiangsu Nanfang Medical Co Headlines

No Headlines